Literature DB >> 10529101

Paramyxovirus reverse genetics is coming of age.

Y Nagai1, A Kato.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10529101     DOI： 10.1111/j.1348-0421.1999.tb02448.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN： 0385-5600            Impact factor:   1.955


× No keyword cloud information.
  23 in total

1.  Comparison of predicted amino acid sequences of measles virus strains in the Edmonston vaccine lineage.

Authors:  C L Parks; R A Lerch; P Walpita; H P Wang; M S Sidhu; S A Udem
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture.

Authors:  Gabriele Neumann; Heinz Feldmann; Shinji Watanabe; Igor Lukashevich; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

3.  "Rule of six": how does the Sendai virus RNA polymerase keep count?

Authors:  D Vulliémoz; L Roux
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

4.  Involvement of the zinc-binding capacity of Sendai virus V protein in viral pathogenesis.

Authors:  C Huang; K Kiyotani; Y Fujii; N Fukuhara; A Kato; Y Nagai; T Yoshida; T Sakaguchi
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

Review 5.  Live-attenuated virus vaccines for respiratory syncytial and parainfluenza viruses: applications of reverse genetics.

Authors:  Brian R Murphy; Peter L Collins
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

6.  Versatility of the accessory C proteins of Sendai virus: contribution to virus assembly as an additional role.

Authors:  M K Hasan; A Kato; M Muranaka; R Yamaguchi; Y Sakai; I Hatano; M Tashiro; Y Nagai
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

7.  Single amino acid substitution in the V protein of simian virus 5 differentiates its ability to block interferon signaling in human and murine cells.

Authors:  D F Young; N Chatziandreou; B He; S Goodbourn; R A Lamb; R E Randall
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

Review 8.  Respiratory syncytial virus vaccine development.

Authors:  Julia L Hurwitz
Journal:  Expert Rev Vaccines       Date:  2011-10       Impact factor: 5.217

9.  Importance of the anti-interferon capacity of Sendai virus C protein for pathogenicity in mice.

Authors:  Atsushi Kato; Katsuhiro Kiyotani; Toru Kubota; Tetsuya Yoshida; Masato Tashiro; Yoshiyuki Nagai
Journal:  J Virol       Date:  2007-01-10       Impact factor: 5.103

10.  Recombinant Newcastle disease virus as a vaccine vector.

Authors:  T Nakaya; J Cros; M S Park; Y Nakaya; H Zheng; A Sagrera; E Villar; A García-Sastre; P Palese
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.